We are international
Donate
• about myeloma TEXT SIZE   


Winter 2005/2006 Volume 6, Issue 7:
Board of Directors Profile: Matthew Robinson
This is a very exciting growth period for the Foundation. And it's enormously rewarding for me to apply my business experience of the last 20 years to helping the IMF accomplish its goals and objectives.
04.20.06

Myeloma Today: What is your professional background?

Matthew Robinson: After receiving my B.A. cum laude in Economics at Harvard University, I completed my MBA at London Business School. I then started my career as an investment banker in New York and London. Then I went to work for one of my clients, the Walt Disney Company, and stayed with them for five years. Ten years ago, I moved to Los Angeles to take a job with Warner Brothers, which is where I've worked ever since.

MT: How did you first learn about the International Myeloma Foundation?

MR: I met Susie Novis about three years ago. She is very passionate about the IMF mission of improving the quality of life of myeloma patients while working toward prevention and a cure. It was from her that first I learned about both the achievements and challenges of the myeloma community.

MT: When did you join the IMF Board of Directors?

MR: Susie approached me in the latter part of 2004. She was looking to diversify the Board by bringing on new Directors, and my international business experience was a logical fit with the Foundations continued global expansion. I am very pleased to be able to contribute my experience to the IMF Board of Directors, and to serve on the Board's Finance Committee and the ad hoc International Committee.

MT: How do you see the Foundations' priorities?

MR: We need to be where the need is. The IMF is committed to providing a broad range of patient and family services. We are here to help address the tangible needs of the myeloma community today, while striving toward the ultimate goal of a cure for this disease. The IMF's fundraising efforts support its myeloma research program, as well as the innovative Bank On A Cure® initiative. Clearly, the IMF's priorities are in the right place.

MT: What is your outlook for the IMF?

MR: It is very positive. With the continued expansion of the Foundation, we are striving to bring the IMF's programs and services to as many members of the myeloma community as possible. This is a very exciting growth period for the Foundation. And it's enormously rewarding for me to apply my business experience of the last 20 years to helping the IMF accomplish its goals and objectives.


 related articles